4//SEC Filing
Chaganti Raju S.K. 4
Accession 0001181431-13-022089
CIK 0001349929other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:15 PM ET
Size
10.5 KB
Accession
0001181431-13-022089
Insider Transaction Report
Form 4
Chaganti Raju S.K.
Director
Transactions
- Conversion
Convertible Note
2013-04-10→ 0 totalExercise: $10.00→ Common Stock (13,430 underlying) - Purchase
Convertible Note
2013-04-10+13,430→ 438,727 total
Footnotes (1)
- [F1]The outstanding principal balance under the convertible note plus all accrued and unpaid interest thereon converted into shares of common stock of Cancer Genetics, Inc. (the "Company") upon consummation of the Company's initial public offering at a conversion price per share equal to the initial public offering price per share. The convertible note had no expiration date.
Issuer
CANCER GENETICS, INC
CIK 0001349929
Entity typeother
Related Parties
1- filerCIK 0001550335
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:15 PM ET
- Size
- 10.5 KB